Evidence map›Paper›PMID 38881889›Full record

ArticleFrontiers in immunology2024

C1q is elevated during chronic

Matthew Beaver, Lara Bergdolt, Anna Dunaevsky, Tammy Kielian, Gwenn L Skar

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew BeaverDepartment of Pediatrics, University of Nebraska Medical Center, Omaha, NE, United States.
Lara BergdoltDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, United States.
Anna DunaevskyDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, United States.
Tammy KielianDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States.
Gwenn L SkarDepartment of Pediatrics, University of Nebraska Medical Center, Omaha, NE, United States.

Funding

The Role of Complement in Cerebrospinal Fluid Shunt InfectionsK08NS110923 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SKAR, GWENN L · 2020 to 2024
$967k
NINDS NIH HHS K08 NS110923
6 · The paper itself

Abstract

Introduction: Significant neurologic morbidity is caused by pediatric cerebrospinal fluid (CSF) shunt infections. The underlying mechanisms leading to impaired school performance and increased risk of seizures are unknown, however, a better understanding of these mechanisms may allow us to temper their consequences. Recent evidence has demonstrated important roles for complement proteins in neurodevelopment and neuroinflammation. Methods: We examined complement activation throughout Results: We found that MASP2 predominated early in catheter infection, but that Factor B was elevated at intermediate time points. Unexpectedly C1q was elevated at late timepoints when bacterial burdens were low or undetectable. Based on these findings and the wealth of information regarding the emerging roles of C1q in the CNS, this suggests functions beyond pathogen elimination during Discussion: Neither C3 nor C5 impacted synaptic protein abundance. These findings suggest that chronic elevations in C1q in the brain that persist once CNS catheter infection has resolved may be modulating disease sequalae.

Indexed as

Catheter-Related InfectionsComplement C1qStaphylococcal InfectionsAnimalsChronic DiseaseComplement ActivationDisease Models, AnimalFemaleMaleMiceMice, Inbred C57BLMice, KnockoutStaphylococcus epidermidisComplement C1qC1qcentral nervous system infectioncerebrospinal fluid shuntcomplementStaphylococcus epidermidis

Identifiers

PMID38881889
PMCPMC11176433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.